Resources
About Us
Meticulous Research®—a leading market research company, published a research report titled, ‘Asia-Pacific Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Forecast to 2030.’
According to this latest publication from Meticulous Research®, the Asia-Pacific Point-of-Care Market is projected to reach $11.80 billion by 2030, at a CAGR of 7.5% from 2024 to 2030. The growth of this market is driven by the increasing prevalence of chronic diseases, innovations in PoC tests, and a lack of skilled technicians for performing lab tests. However, the pricing pressure due to fluctuations in reimbursements restrains the market’s growth. Furthermore, healthcare professionals’ increasing preference for PoC tests over lab tests will offer significant market growth opportunities. However, a lack of awareness regarding the use of PoC devices challenges the market’s growth.
Key Players:
The key players operating in the Asia-Pacific Point-of-Care market are Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Trinity Biotech plc (Ireland), Werfen (Spain), Nova Biomedical (U.S.), Sekisui Diagnostics, LLC. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and bioMérieux S.A. (France).
The Asia-Pacific Point-of-Care market is segmented by Offering (Consumables, Instruments, and Software and Services); Platform (Lateral Flow Assays, Molecular Diagnostics, and Other Platform); Application (Blood Glucose Monitoring, Infectious Disease Testing [Parasitic Infections Testing, Blood-Borne Infections Testing {Hepatitis, HIV, Other Blood-Borne Infections}, Respiratory Infections Testing {Influenza, Pneumonia, Other Respiratory Infections Testing}, Healthcare-Associated Infection (HAI) Testing, Gastrointestinal Infections Testing {Salmonellosis, E. Coli Infections, Other GI Infections} Other Infectious Diseases Testing], COVID-19 Testing, Tumor/Cancer Markers Testing, Pregnancy and Fertility Testing [Pregnancy Testing, Fertility Testing], Cardiac Marker/Cardiac Metabolism Testing, Cholesterol/Lipid Profile Testing, Coagulation Testing [Prothrombin Time (PT/INR) Testing, Activated Clotting Time (ACT/APTT) Testing, Other Coagulation Testing], Hematology, Drugs Of Abuse Testing, Urinalysis, Other Poc Testing); Sample Type (Blood Sample, Nasopharyngeal Swab, Urine Sample, Saliva Sample, Other Sample Types); End User (Home Care/Self-Testing, Hospitals, Physician Offices & Ambulatory Care Settings, Diagnostics Laboratories, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes the country-level markets.
Among the offerings included in the report, in 2024, the consumables segment is expected to account for the largest share of the Asia-Pacific Point-of-Care market. The large market share of this segment can be attributed to the repeated utilization of consumables for POC testing, developments in direct-to-customer tests, and a surge in product approvals.
Among the platforms included in the report, in 2024, the lateral flow assays segment is expected to account for the largest share of the Asia-Pacific Point-of-Care market. The large market share of this segment can be attributed to new product launches, low development costs, and ease of production. Also, the COVID-19 pandemic led to an increased demand for lateral flow assays, due to which there were several new products in the market. For instance, in October 2020, Siemens Healthineers AG (Germany) launched its CLINITEST Rapid COVID-19 antigen test, a point-of-care cassette test, which helps deliver results in 15 minutes.
Among the applications included in the report, in 2024, the blood glucose monitoring segment is expected to account for the largest share of the Asia-Pacific Point-of-Care market. According to the International Diabetes Federation’s (IDF) Diabetes Atlas, in Southeast Asia, the number of adults with diabetes is estimated to reach 113 million by 2030 from 90 million in 2021. Hence, the increasing prevalence of diabetes and simultaneously the need for blood glucose monitoring contributed to the largest market share of the segment.
Among the sample types included in the report, in 2024, the blood sample type segment is expected to account for the largest share of the Asia-Pacific Point-of-Care market. The large market share of this segment can be attributed to the availability of a large variety of tests using blood samples, which includes blood glucose testing, rapid cardiac markers diagnostics, drugs of abuse screening, infectious disease testing, and the increased prevalence of various chronic diseases.
Among the end user included in the report, in 2024, the hospital segment is expected to account for the largest share of the Asia-Pacific Point-of-Care market. Point-of-care (PoC) devices are utilized across different hospital departments, including the emergency department (ED), intensive care unit (ICU), operating room/reanimation, and delivery room/neonatal ward. Given the diverse range of medical tests conducted within hospitals to diagnose various conditions, the global rise in healthcare expenditure provides a significant factor in the growth of the point-of-care diagnostics market.
This research report analyzes major geographies in Asia-Pacific, namely Japan, China, India, South Korea, Australia, New Zealand, Singapore, Thailand, and the Rest of Asia-Pacific. In 2024, China is expected to account for the largest share of the Asia-Pacific Point-of-Care market. Some of the major factors contributing to the largest share include the presence of a large number of hospitals and diagnostic centers and support from public and private organizations toward the adoption of advanced healthcare facilities.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5671
Key questions answered in the report:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Bakuchiol Serum Market to Reach $4.41 Million by 2031
Read MoreBurn Care Market to be Worth $4.32 Billion by 2031
Read MoreAfrica Medical Devices Market to be Worth $7.14 Billion by 2031
Read MoreMiddle East Medical Devices Market to be Worth $8.8 Billion by 2031
Read MoreSurgical Drills Market to be Worth $1.71 Billion by 2031
Read MoreTissue Engineering Market to reach $7.41 Billion by 2031
Read MoreDental Prosthetics Market to be Worth $ 19.6 Billion by 2031
Read MoreWhole Genome Sequencing Market to be Worth $7.17 Billion by 2031
Read MoreIVD Assay Development Market to be Worth $8.39 Billion by 2031
Read MoreNeurogenomics Market to Reach $4.68 Billion by 2031
Read MoreIndia VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MoreViral Vaccines Market to be Worth $64.18 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreU.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreDigital Therapeutics Market to be Worth $56.34 Billion by 2031
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market to Reach $7.09 Billion by 2031
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More